Please login (Members) to view content or
(Nonmembers) this article.
No votes yet
Oncology Essentials

Individualizing Care for Women With Early-Stage Breast Cancer: The Role of Molecular Assays

Georgia Litsas
CJON 2013, 17(3), 332-334 DOI: 10.1188/13.CJON.332-334

Traditionally, a variety of factors were used to make adjuvant treatment decisions in breast cancer, but none of those factors, except grade, has a consistent association with sensitivity to chemotherapy or endocrine therapy. However, oncologists now are able to use molecular assays as a component of decision making for adjuvant therapy. This article focuses on the use of two of those molecular assays and their implications for nurses.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or